Vulnerabilities · 2017 · Bmc
CVE-2017-17678
Bmc Remedy Mid-tier vulnerability
BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability was discovered in a legacy utility.
Affected products
Remedy Mid-tier. The exact versions are in the references.
What to do now
- Check your exposureFind out whether Bmc Remedy Mid-tier runs anywhere in your environment, including systems of suppliers.
- UpdateInstall the version in which the vendor fixed the vulnerability. The references lead to the advisory.
- Limit access until thenIf you cannot update at once, take the system off the internet or restrict who can reach it.
References
More vulnerabilities in Bmc products
CVE-2025-55117CVE-2025-55116CVE-2025-55115CVE-2025-55113CVE-2025-55112CVE-2025-55111CVE-2025-55109CVE-2025-48709All 72
Data: CVE list and the NVD. This product uses data from the NVD API but is not endorsed or certified by the NVD.